stella
beta
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC — Stella
Recruiting
Back to Metastatic Microsatellite Stable Colorectal Carcinoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Icahn School of Medicine at Mount Sinai, New York, New York
View full record on ClinicalTrials.gov